✦ LIBER ✦

Comparison of motor strategies in sit-to-stand and back-to-sit motions between healthy and Alzheimer’s disease elderly subjects

✍ Scribed by P. Manckoundia; F. Mourey; P. Pfitzenmeyer; C. Papaxanthis

Book ID: 116787381
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 288 KB
Volume: 137
Category: Article
ISSN: 0306-4522
DOI: 10.1016/j.neuroscience.2005.08.079

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Joint torques during sit-to-stand in hea

Joint torques during sit-to-stand in healthy subjects and people with Parkinson’s disease

✍ Margaret K.Y. Mak; Oron Levin; Joseph Mizrahi; Christina W.Y. Hui-Chan 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 218 KB

Joint torques during sit-to-stand in hea

Joint torques during sit-to-stand in healthy subjects and people with Parkinson’s disease

✍ Margaret K.Y. Mak; Oron Levin; Joseph Mizrahi; Christina W.Y. Hui-Chan 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 218 KB

## Objectives: To compare lower limb joint torques during sit-to-stand in normal elderly subjects and people with parkinson's disease, using a developed biomechanical model simulating all phases of sit-to-stand.design. a cross-sectional study utilizing a parkinsonian and a control group. ## Backgr

The effect of the partially restricted s

The effect of the partially restricted sit-to-stand task on biomechanical variables in subjects with and without Parkinson’s disease

✍ Luciane Aparecida Pascucci Sande de Souza; Mônica de Biagi Curtarelli; Mukul Muk 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 702 KB

FP43-TH-04 Twelve months follow-up study

FP43-TH-04 Twelve months follow-up study of fractional anisotropy changes in mild cognitive impairment and Alzheimer's disease patients compared to healthy elderly subjects

✍ Y. Likitjaroen; T. Meindl; M. Wagner; K. Bürger; H. Hampel; S.J. Teipel 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

A Positron Emission Tomography Study to

A Positron Emission Tomography Study to Assess Binding of Lecozotan, a Novel 5-Hydroxytryptamine-1A Silent Antagonist, to Brain 5-HT1A Receptors in Healthy Young and Elderly Subjects, and in Patients With Alzheimer's Disease

✍ Raje, S; Patat, A A; Parks, V; Schechter, L; Plotka, A; Paul, J; Langstrom, B 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 236 KB